Skip to content
Home/Companies/Pharma/VISUfarma
VI

VISUfarma

Pharma·UK·Exited 2026·Held 10yr

VISUfarma is a healthcare company, headquartered in UK.

Entry
2016
Hold
10yr
Exit
2026
Est. EV
–

Who owns VISUfarma?

VISUfarma was owned by GHO Capital through GHO Capital Fund I LP (2015 vintage) from 2016 to 2026, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

GHO Capital
Investor
GHO Capital
GHO Capital Fund I LP · 2015 · Buyout

Key facts

HQUK
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026

More from GHO Capital Fund I LP

Other portfolio companies in the same fund.

BioAgilytix
Exited 2021
BiotechUnited States· 2018
to
Caprion Biosciences
Exited 2019
BiotechCanada· 2016
to
DNA Diagnostics Center
Exited 2021
HealthcareUnited States· 2015
to
Quotient Sciences
Exited 2019
PharmaUK· 2015
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings